JUNEE LTD (JUNE) Fundamental Analysis & Valuation

NASDAQ:JUNE • VGG5294K1104

Current stock price

11.5 USD
+0.7 (+6.48%)
At close:
11.52 USD
+0.02 (+0.17%)
After Hours:

This JUNE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. JUNE Profitability Analysis

1.1 Basic Checks

  • In the past year JUNE has reported negative net income.
  • In the past year JUNE has reported a negative cash flow from operations.
JUNE Yearly Net Income VS EBIT VS OCF VS FCFJUNE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 500K -500K -1M

1.2 Ratios

  • JUNE has a worse Return On Assets (-13.56%) than 63.89% of its industry peers.
  • With a Return On Equity value of -15.58%, JUNE perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
Industry RankSector Rank
ROA -13.56%
ROE -15.58%
ROIC N/A
ROA(3y)-3.75%
ROA(5y)N/A
ROE(3y)-4.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
JUNE Yearly ROA, ROE, ROICJUNE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

  • JUNE has a Gross Margin of 26.83%. This is in the lower half of the industry: JUNE underperforms 66.67% of its industry peers.
  • JUNE's Gross Margin has improved in the last couple of years.
  • JUNE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.38%
GM growth 5YN/A
JUNE Yearly Profit, Operating, Gross MarginsJUNE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 20 -20

7

2. JUNE Health Analysis

2.1 Basic Checks

  • JUNE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, JUNE has less shares outstanding
  • The debt/assets ratio for JUNE has been reduced compared to a year ago.
JUNE Yearly Shares OutstandingJUNE Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M
JUNE Yearly Total Debt VS Total AssetsJUNE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2M 4M 6M 8M

2.2 Solvency

  • An Altman-Z score of 130.92 indicates that JUNE is not in any danger for bankruptcy at the moment.
  • With an excellent Altman-Z score value of 130.92, JUNE belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
  • A Debt/Equity ratio of 0.01 indicates that JUNE is not too dependend on debt financing.
  • JUNE has a Debt to Equity ratio of 0.01. This is in the better half of the industry: JUNE outperforms 69.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z 130.92
ROIC/WACCN/A
WACC15.99%
JUNE Yearly LT Debt VS Equity VS FCFJUNE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 2M 4M 6M

2.3 Liquidity

  • A Current Ratio of 8.25 indicates that JUNE has no problem at all paying its short term obligations.
  • JUNE has a better Current ratio (8.25) than 93.06% of its industry peers.
  • JUNE has a Quick Ratio of 8.25. This indicates that JUNE is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Quick ratio value of 8.25, JUNE belongs to the best of the industry, outperforming 93.06% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 8.25
Quick Ratio 8.25
JUNE Yearly Current Assets VS Current LiabilitesJUNE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2M 4M 6M

0

3. JUNE Growth Analysis

3.1 Past

  • The earnings per share for JUNE have decreased strongly by -7200.00% in the last year.
  • The Revenue for JUNE has decreased by -50.14% in the past year. This is quite bad
  • JUNE shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -22.76% yearly.
EPS 1Y (TTM)-7200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2660%
Revenue 1Y (TTM)-50.14%
Revenue growth 3Y-22.76%
Revenue growth 5YN/A
Sales Q2Q%-52.72%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
JUNE Yearly Revenue VS EstimatesJUNE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2M 4M 6M 8M

0

4. JUNE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for JUNE. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
JUNE Price Earnings VS Forward Price EarningsJUNE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
JUNE Per share dataJUNE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 0.2 0.3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. JUNE Dividend Analysis

5.1 Amount

  • No dividends for JUNE!.
Industry RankSector Rank
Dividend Yield N/A

JUNE Fundamentals: All Metrics, Ratios and Statistics

JUNEE LTD

NASDAQ:JUNE (5/30/2025, 8:09:58 PM)

After market: 11.52 +0.02 (+0.17%)

11.5

+0.7 (+6.48%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners3.49%
Inst Owner Change116.97%
Ins Owners6.9%
Ins Owner ChangeN/A
Market Cap225.75M
Revenue(TTM)4.57M
Net Income(TTM)-1.09M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 49.45
P/FCF N/A
P/OCF N/A
P/B 32.41
P/tB 32.41
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.04
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.23
BVpS0.35
TBVpS0.35
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -13.56%
ROE -15.58%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.83%
FCFM N/A
ROA(3y)-3.75%
ROA(5y)N/A
ROE(3y)-4.74%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y14.38%
GM growth 5YN/A
F-Score4
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 61.32%
Cap/Sales 0.14%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 8.25
Quick Ratio 8.25
Altman-Z 130.92
F-Score4
WACC15.99%
ROIC/WACCN/A
Cap/Depr(3y)87.22%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.19%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7200%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-2660%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-50.14%
Revenue growth 3Y-22.76%
Revenue growth 5YN/A
Sales Q2Q%-52.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-466.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-2585.9%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1766.74%
OCF growth 3YN/A
OCF growth 5YN/A

JUNEE LTD / JUNE Fundamental Analysis FAQ

What is the fundamental rating for JUNE stock?

ChartMill assigns a fundamental rating of 2 / 10 to JUNE.


What is the valuation status for JUNE stock?

ChartMill assigns a valuation rating of 0 / 10 to JUNEE LTD (JUNE). This can be considered as Overvalued.


What is the profitability of JUNE stock?

JUNEE LTD (JUNE) has a profitability rating of 1 / 10.


Can you provide the financial health for JUNE stock?

The financial health rating of JUNEE LTD (JUNE) is 7 / 10.